News: Provectus Equity Offering $PVCT

Provectus Biopharmaceuticals., has announced the equity offering of Common stock and warrants. The net proceeds would be used in clinical development, working capital and general corporate purposes. Offer is yet to be approved by the authorities. View the full release here.

Endocyte Revenues Rise $ECYT $XHS

Endocyte, Inc., a bio pharmaceutical company, develops therapies for the treatment of cancer and inflammatory diseases, has announced its results for first quarter of FY-2015. The results shows, Revenues rise to $ 17,269,000  from $ 12,000, and EPS improves from -$0.26 to -$0.09 . View the full earnings release here.